Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 15Colorectal Neoplasms 13Lung Neoplasms 12Neoplasms 11Stomach Neoplasms 9Neoplasm Metastasis 6Colonic Neoplasms 6Esophageal Neoplasms 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Osteosarcoma 3Multiple Myeloma 3Melanoma 3Lymphoma, Follicular 3Lymphoma 3Waldenstrom Macroglobulinemia 2Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Thymus Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Rectal Neoplasms 2

Interventions

Liquid Biopsy 4Blood Specimen Collection 4Gemcitabine 3pembrolizumab 2Immunohistochemistry 2Cisplatin 2Capecitabine 2Base Sequence 2130-nm albumin-bound paclitaxel 2tislelizumab 1taxane 1lenvatinib 1irinotecan sucrosofate 1gemcitabine-oxaliplatin regimen 1Tegafur 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1S 1 (combination) 1Polymerase Chain Reaction 1Platinum Compounds 1Oxaliplatin 1Nivolumab 1Microscopy, Confocal 1Methylation 1Mass Spectrometry 1Leucovorin 1Irinotecan 1Immune Checkpoint Inhibitors 1High-Throughput Nucleotide Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Biliary Tract Neoplasms × Drug Therapy × Clear all
NCT06975917 2025-05-16

TOG-SAFRADJU

Ankara University

Active not recruiting
600 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡